vs
Mind Medicine (MindMed) Inc.（DFTX）与优莎娜（USNA）财务数据对比。点击上方公司名可切换其他公司
优莎娜的季度营收约是Mind Medicine (MindMed) Inc.的235.8倍（$213.7M vs $906.0K）。优莎娜净利率更高（-3.1% vs -2634.0%，领先2630.9%）。优莎娜同比增速更快（6.7% vs -16.1%）
Definium Therapeutics（前称MindMed）是一家总部位于纽约的生物技术企业，专注于致幻剂及更广泛的精神可塑性药物的临床与治疗应用开发，在中枢神经药物研发领域深耕相关创新疗法的落地潜力。
USANA是总部位于美国犹他州盐湖城的多层次营销企业，以 revenue 计位列2021年全球第14大直销企业。公司主打营养产品、膳食补充剂与护肤产品，大部分产品在盐湖城自有工厂生产，产品通过独立经销商网络销往全球24个国家。
DFTX vs USNA — 直观对比
营收规模更大
USNA
是对方的235.8倍
$906.0K
营收增速更快
USNA
高出22.8%
-16.1%
净利率更高
USNA
高出2630.9%
-2634.0%
损益表 — Q4 2023 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $906.0K | $213.7M |
| 净利润 | $-23.9M | $-6.5M |
| 毛利率 | — | 77.2% |
| 营业利润率 | -2450.8% | 0.6% |
| 净利率 | -2634.0% | -3.1% |
| 营收同比 | -16.1% | 6.7% |
| 净利润同比 | -386.7% | -161.5% |
| 每股收益（稀释后） | $-0.58 | $-0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DFTXUSNA
| Q3 25 | — | $213.7M | ||
| Q2 25 | — | $235.8M | ||
| Q1 25 | — | $249.5M | ||
| Q4 24 | — | $213.6M | ||
| Q3 24 | — | $200.2M | ||
| Q2 24 | — | $212.9M | ||
| Q1 24 | — | $227.8M | ||
| Q4 23 | $906.0K | $221.1M |
净利润DFTXUSNA
| Q3 25 | — | $-6.5M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $10.6M | ||
| Q2 24 | — | $10.4M | ||
| Q1 24 | — | $16.5M | ||
| Q4 23 | $-23.9M | — |
毛利率DFTXUSNA
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | 81.1% | ||
| Q1 24 | — | 81.1% | ||
| Q4 23 | — | 80.9% |
营业利润率DFTXUSNA
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 7.1% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 10.8% | ||
| Q4 23 | -2450.8% | 11.0% |
净利率DFTXUSNA
| Q3 25 | — | -3.1% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 4.9% | ||
| Q1 24 | — | 7.3% | ||
| Q4 23 | -2634.0% | — |
每股收益（稀释后）DFTXUSNA
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.49 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | — | $0.56 | ||
| Q2 24 | — | $0.54 | ||
| Q1 24 | — | $0.86 | ||
| Q4 23 | $-0.58 | $0.87 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $99.7M | $145.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $78.1M | $528.1M |
| 总资产 | $124.5M | $726.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DFTXUSNA
| Q3 25 | — | $145.3M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | — | $179.6M | ||
| Q4 24 | — | $181.8M | ||
| Q3 24 | — | $364.9M | ||
| Q2 24 | — | $332.4M | ||
| Q1 24 | — | $328.3M | ||
| Q4 23 | $99.7M | $330.4M |
股东权益DFTXUSNA
| Q3 25 | — | $528.1M | ||
| Q2 25 | — | $531.1M | ||
| Q1 25 | — | $529.8M | ||
| Q4 24 | — | $532.1M | ||
| Q3 24 | — | $533.1M | ||
| Q2 24 | — | $512.2M | ||
| Q1 24 | — | $500.0M | ||
| Q4 23 | $78.1M | $497.2M |
总资产DFTXUSNA
| Q3 25 | — | $726.6M | ||
| Q2 25 | — | $734.5M | ||
| Q1 25 | — | $746.6M | ||
| Q4 24 | — | $748.2M | ||
| Q3 24 | — | $671.3M | ||
| Q2 24 | — | $631.4M | ||
| Q1 24 | — | $629.3M | ||
| Q4 23 | $124.5M | $632.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.6M | $-2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-5.2M |
| 自由现金流率自由现金流/营收 | — | -2.4% |
| 资本支出强度资本支出/营收 | — | 1.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $18.7M |
8季度趋势，按日历期对齐
经营现金流DFTXUSNA
| Q3 25 | — | $-2.0M | ||
| Q2 25 | — | $12.2M | ||
| Q1 25 | — | $15.5M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | — | $29.5M | ||
| Q2 24 | — | $8.0M | ||
| Q1 24 | — | $17.7M | ||
| Q4 23 | $-20.6M | $26.0M |
自由现金流DFTXUSNA
| Q3 25 | — | $-5.2M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $12.7M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $27.1M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $14.5M | ||
| Q4 23 | — | $18.7M |
自由现金流率DFTXUSNA
| Q3 25 | — | -2.4% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 6.4% | ||
| Q4 23 | — | 8.5% |
资本支出强度DFTXUSNA
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 1.4% | ||
| Q4 23 | — | 3.3% |
现金转化率DFTXUSNA
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 1.07× | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DFTX
暂无分部数据
USNA
| Direct Selling | $175.8M | 82% |
| Hiya | $30.8M | 14% |
| All Other | $7.0M | 3% |
